4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine

C46H46Br2N16O — CID 159906501

IUPAC4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine
SMILESCC(C)(C)Nc1ccc(-c2cnc(N)nc2)cc1N.CC(C)(C)n1c(-c2cc(Br)ccc2-n2cncn2)nc2cc(-c3cnc(N)nc3)ccc21.O=Cc1cc(Br)ccc1-n1cncn1
InChIInChI=1S/C23H21BrN8.C14H19N5.C9H6BrN3O/c1-23(2,3)32-20-6-4-14(15-10-27-22(25)28-11-15)8-18(20)30-21(32)17-9-16(24)5-7-19(17)31-13-26-12-29-31;1-14(2,3)19-12-5-4-9(6-11(12)15)10-7-17-13(16)18-8-10;10-8-1-2-9(7(3-8)4-14)13-6-11-5-12-13/h4-13H,1-3H3,(H2,25,27,28);4-8,19H,15H2,1-3H3,(H2,16,17,18);1-6H
InChIKeyNWQIVBXEPDIHPA-UHFFFAOYSA-N
MW998.79 g/mol
LogP9.20
Rot. Bonds7

About 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine

4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine (PubChem CID 159906501) has the molecular formula C46H46Br2N16O and a molecular weight of 998.79 g/mol. Its IUPAC name is 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine.

Molecular Properties

Compound Name4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine
PubChem CID159906501
Molecular FormulaC46H46Br2N16O
Molecular Weight998.79 g/mol
Exact Mass996.24
IUPAC Name4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine
SMILESCC(C)(C)Nc1ccc(-c2cnc(N)nc2)cc1N.CC(C)(C)n1c(-c2cc(Br)ccc2-n2cncn2)nc2cc(-c3cnc(N)nc3)ccc21.O=Cc1cc(Br)ccc1-n1cncn1
InChIInChI=1S/C23H21BrN8.C14H19N5.C9H6BrN3O/c1-23(2,3)32-20-6-4-14(15-10-27-22(25)28-11-15)8-18(20)30-21(32)17-9-16(24)5-7-19(17)31-13-26-12-29-31;1-14(2,3)19-12-5-4-9(6-11(12)15)10-7-17-13(16)18-8-10;10-8-1-2-9(7(3-8)4-14)13-6-11-5-12-13/h4-13H,1-3H3,(H2,25,27,28);4-8,19H,15H2,1-3H3,(H2,16,17,18);1-6H
InChIKeyNWQIVBXEPDIHPA-UHFFFAOYSA-N
XLogP9.20
TPSA237.96 Ų
H-Bond Donors4
H-Bond Acceptors17
Rotatable Bonds7
Heavy Atoms65
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500998.79
LogP ≤ 59.20
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine?
The IUPAC name of 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine (CID 159906501) is 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine.
What is the SMILES notation for 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine?
The canonical SMILES for 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine is CC(C)(C)Nc1ccc(-c2cnc(N)nc2)cc1N.CC(C)(C)n1c(-c2cc(Br)ccc2-n2cncn2)nc2cc(-c3cnc(N)nc3)ccc21.O=Cc1cc(Br)ccc1-n1cncn1.
What is the InChIKey of 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine?
The InChIKey is NWQIVBXEPDIHPA-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H21BrN8.C14H19N5.C9H6BrN3O/c1-23(2,3)32-20-6-4-14(15-10-27-22(25)28-11-15)8-18(20)30-21(32)17-9-16(24)5-7-19(17)31-13-26-12-29-31;1-14(2,3)19-12-5-4-9(6-11(12)15)10-7-17-13(16)18-8-10;10-8-1-2-9(7(3-8)4-14)13-6-11-5-12-13/h4-13H,1-3H3,(H2,25,27,28);4-8,19H,15H2,1-3H3,(H2,16,17,18);1-6H.
What are the key properties of 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine?
4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine has a molecular weight of 998.79 g/mol, XLogP of 9.20, 7 rotatable bonds, 4 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;5-bromo-2-(1,2,4-triazol-1-yl)benzaldehyde;5-[2-[5-bromo-2-(1,2,4-triazol-1-yl)phenyl]-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine is sourced from PubChem (CID 159906501), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).